DoW Kidney Cancer, Academy of Kidney Cancer Investigators - Early-Career Scholar Award
Defense Health Agency Contracting Activity - DHACA
Free. Verify your email, then we send one reminder only.
- Posted
- Jun 18, 2026
- Amount
- Program total $2.4M
- Closes
- Sep 28, 2026 (in 11 days)
Similar opportunities open now
- DoW Kidney Cancer, Idea Development AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 11 days
- DoW, Ovarian Cancer, Ovarian Cancer Clinical Trial Academy – Early-Career Investigator AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 14 days
- DoW Rare Cancers Resource and Community Development AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 62 days
- Damon Runyon Clinical Investigator AwardOpenDamon Runyon Cancer Research FoundationCloses Jan 2027
- DoW Parkinson’s, Early Investigator Research AwardSame funderOpenDefense Health Agency Contracting Activity - DHACACloses in 50 days
Classification and identifiers
- Solicitation number
- HT942526KCRPAKCIECSA
- Assistance listing (CFDA)
- 12.420
Amount
Program total $2.4M
Who can apply
About this opportunity
Summary: Initially created in fiscal year 2019 (FY19), the Kidney Cancer Research Program (KCRP) Academy of Kidney Cancer Investigators (AKCI) is a unique interactive virtual academy providing intensive mentoring, national networking, collaborations, and a peer group for junior faculty. The Academy pairs Early Career Scholars (ECS) with established investigators (Designated Mentors) under the oversight of the AKCI Leadership Team, a Designated Mentor Panel, and the Kidney Cancer Patient Advocates Panel. The AKCI’s overarching goal is to conduct innovative and impactful kidney cancer research while also developing a vital resource, a network of highly productive kidney cancer researchers conducting cutting edge research that advances the state of the field in kidney cancer and leads to new ...